drugset / Trial / NCT00031720
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
Phase 2
Completed
112 enrolled
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI) · collabProtein Technologies International · collab
RandomizedParallel-groupDouble-blindSupportive care
Summary
RATIONALE: Soy protein supplement may be effective in reducing hot flushes in postmenopausal women who are receiving tamoxifen for breast disease. PURPOSE: Randomized phase II trial to determine the effectiveness of soy protein supplement in reducing hot flushes in postmenopausal women who are receiving tamoxifen for breast disease such as ductal hyperplasia or breast cancer.
Timeline
- Start
- 2002-03
- Primary completion
- 2006-04
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Tamoxifen | Small molecule | — | — |